Nifty
Sensex
:
:
18726.40
63142.96
127.40 (0.69%)
350.08 (0.56%)

Pharmaceuticals & Drugs - Global

Rating :
63/99

BSE: 500420 | NSE: TORNTPHARM

1802.05
07-Jun-2023
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 1800.95
  • 1814.90
  • 1790.05
  • 1788.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  249842
  •  4500.48
  •  1884.90
  •  1359.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 60,539.43
  • 48.83
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 64,154.12
  • 1.23%
  • 9.81

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 71.25%
  • 0.33%
  • 4.47%
  • FII
  • DII
  • Others
  • 12.04%
  • 8.34%
  • 3.57%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.23
  • 7.42
  • 2.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.39
  • 12.50
  • 2.30

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.03
  • 2.76
  • -8.80

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 37.95
  • 42.77
  • 41.13

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.94
  • 7.42
  • 8.24

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.14
  • 19.59
  • 20.67

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Net Sales
2,491.00
2,131.00
16.89%
2,491.00
2,108.00
18.17%
2,291.00
2,137.00
7.21%
2,347.00
2,134.00
9.98%
Expenses
1,764.00
1,570.00
12.36%
1,767.00
1,570.00
12.55%
1,612.00
1,477.00
9.14%
1,635.00
1,457.00
12.22%
EBITDA
727.00
561.00
29.59%
724.00
538.00
34.57%
679.00
660.00
2.88%
712.00
677.00
5.17%
EBIDTM
29.19%
26.33%
29.06%
25.52%
29.64%
30.88%
30.34%
31.72%
Other Income
9.00
56.00
-83.93%
-10.00
48.00
-
16.00
51.00
-68.63%
30.00
40.00
-25.00%
Interest
107.00
57.00
87.72%
102.00
62.00
64.52%
69.00
71.00
-2.82%
55.00
68.00
-19.12%
Depreciation
196.00
162.00
20.99%
193.00
167.00
15.57%
163.00
168.00
-2.98%
155.00
165.00
-6.06%
PBT
433.00
-87.00
-
419.00
357.00
17.37%
463.00
472.00
-1.91%
532.00
484.00
9.92%
Tax
146.00
31.00
370.97%
136.00
108.00
25.93%
151.00
156.00
-3.21%
178.00
154.00
15.58%
PAT
287.00
-118.00
-
283.00
249.00
13.65%
312.00
316.00
-1.27%
354.00
330.00
7.27%
PATM
11.52%
-5.54%
11.36%
11.81%
13.62%
14.79%
15.08%
15.46%
EPS
8.48
-3.49
-
8.36
7.36
13.59%
9.22
9.34
-1.28%
10.46
9.75
7.28%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
9,620.00
8,508.04
8,004.57
7,939.31
7,672.80
5,949.83
5,815.69
6,666.85
4,653.45
4,184.72
3,211.14
Net Sales Growth
13.04%
6.29%
0.82%
3.47%
28.96%
2.31%
-12.77%
43.27%
11.20%
30.32%
 
Cost Of Goods Sold
2,735.00
2,230.75
1,960.12
1,981.79
2,041.26
1,535.17
1,629.66
1,432.13
1,280.96
1,107.58
807.98
Gross Profit
6,885.00
6,277.29
6,044.45
5,957.52
5,631.54
4,414.66
4,186.03
5,234.72
3,372.49
3,077.14
2,403.16
GP Margin
71.57%
73.78%
75.51%
75.04%
73.40%
74.20%
71.98%
78.52%
72.47%
73.53%
74.84%
Total Expenditure
6,778.00
6,076.77
5,524.49
5,768.95
5,696.31
4,600.58
4,438.42
3,937.05
3,633.29
3,233.24
2,518.92
Power & Fuel Cost
-
144.19
122.94
128.19
132.46
118.77
107.98
92.59
97.41
71.88
62.80
% Of Sales
-
1.69%
1.54%
1.61%
1.73%
2.00%
1.86%
1.39%
2.09%
1.72%
1.96%
Employee Cost
-
1,526.45
1,439.62
1,429.04
1,403.79
1,135.25
993.41
842.35
841.81
741.10
623.29
% Of Sales
-
17.94%
17.98%
18.00%
18.30%
19.08%
17.08%
12.63%
18.09%
17.71%
19.41%
Manufacturing Exp.
-
591.13
550.92
544.11
558.84
457.58
502.16
353.45
345.98
320.78
278.15
% Of Sales
-
6.95%
6.88%
6.85%
7.28%
7.69%
8.63%
5.30%
7.43%
7.67%
8.66%
General & Admin Exp.
-
637.65
633.48
801.98
763.90
677.71
578.05
637.92
463.28
398.98
324.55
% Of Sales
-
7.49%
7.91%
10.10%
9.96%
11.39%
9.94%
9.57%
9.96%
9.53%
10.11%
Selling & Distn. Exp.
-
884.91
742.63
807.39
738.03
641.30
567.70
547.05
574.40
461.53
393.07
% Of Sales
-
10.40%
9.28%
10.17%
9.62%
10.78%
9.76%
8.21%
12.34%
11.03%
12.24%
Miscellaneous Exp.
-
61.69
74.78
76.45
58.03
34.80
59.46
31.56
29.45
131.39
393.07
% Of Sales
-
0.73%
0.93%
0.96%
0.76%
0.58%
1.02%
0.47%
0.63%
3.14%
0.91%
EBITDA
2,842.00
2,431.27
2,480.08
2,170.36
1,976.49
1,349.25
1,377.27
2,729.80
1,020.16
951.48
692.22
EBITDA Margin
29.54%
28.58%
30.98%
27.34%
25.76%
22.68%
23.68%
40.95%
21.92%
22.74%
21.56%
Other Income
45.00
196.56
56.91
121.30
63.62
298.84
223.30
228.80
285.55
38.13
43.36
Interest
333.00
255.06
352.94
450.71
503.75
308.48
205.56
183.98
175.16
58.63
33.80
Depreciation
707.00
662.16
657.79
654.38
617.69
408.60
306.92
237.55
190.74
87.00
82.69
PBT
1,847.00
1,710.61
1,526.26
1,186.57
918.67
931.01
1,088.09
2,537.07
939.81
843.98
619.09
Tax
611.00
448.73
274.38
161.85
125.35
252.87
154.51
610.17
188.84
180.07
146.69
Tax Rate
33.08%
36.60%
17.98%
13.64%
22.32%
27.16%
14.20%
26.04%
20.09%
21.34%
25.22%
PAT
1,236.00
777.18
1,251.88
1,024.72
436.28
678.11
933.55
1,733.24
750.94
663.88
432.76
PAT before Minority Interest
1,236.00
777.18
1,251.88
1,024.72
436.31
678.14
933.58
1,733.27
750.97
663.91
434.91
Minority Interest
0.00
0.00
0.00
0.00
-0.03
-0.03
-0.03
-0.03
-0.03
-0.03
-2.15
PAT Margin
12.85%
9.13%
15.64%
12.91%
5.69%
11.40%
16.05%
26.00%
16.14%
15.86%
13.48%
PAT Growth
59.07%
-37.92%
22.17%
134.88%
-35.66%
-27.36%
-46.14%
130.81%
13.11%
53.41%
 
EPS
36.52
22.97
36.99
30.28
12.89
20.04
27.59
51.22
22.19
19.62
12.79

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
5,952.95
5,837.17
4,823.22
4,724.35
4,622.19
4,350.13
3,494.10
2,490.56
1,902.43
1,421.93
Share Capital
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
84.62
42.31
Total Reserves
5,868.33
5,752.55
4,738.60
4,639.73
4,537.57
4,265.51
3,409.48
2,405.94
1,817.81
1,379.62
Non-Current Liabilities
2,238.15
2,924.20
3,299.15
3,861.40
4,142.42
2,303.33
1,994.65
2,504.92
926.76
619.81
Secured Loans
2,123.22
2,941.07
3,302.29
3,909.81
4,105.31
2,229.57
1,839.46
2,171.60
730.72
403.19
Unsecured Loans
0.00
0.00
1.56
3.11
6.15
11.26
10.62
13.62
13.74
51.35
Long Term Provisions
368.74
369.62
338.34
288.52
286.66
263.04
246.36
207.49
190.43
129.51
Current Liabilities
4,415.09
4,891.62
5,454.16
5,165.32
5,202.17
2,738.26
3,285.48
2,823.75
2,174.58
1,710.65
Trade Payables
1,674.44
2,066.81
2,048.81
2,096.74
2,048.24
1,749.32
2,260.22
1,827.72
1,429.13
1,067.74
Other Current Liabilities
1,365.10
1,635.36
1,860.80
1,641.26
1,151.68
687.14
822.28
446.15
371.63
275.83
Short Term Borrowings
923.04
704.40
1,090.85
934.11
1,625.60
0.00
3.32
319.07
210.43
124.62
Short Term Provisions
452.51
485.05
453.70
493.21
376.65
301.80
199.66
230.81
163.39
242.46
Total Liabilities
12,606.19
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76
Net Block
6,422.65
7,064.63
7,533.12
7,747.71
7,854.68
3,688.44
2,859.08
2,832.66
875.34
819.82
Gross Block
10,728.19
10,511.53
10,334.13
9,935.43
9,449.48
4,909.80
3,793.53
3,542.93
1,420.04
1,278.15
Accumulated Depreciation
4,031.06
3,446.90
2,801.01
2,187.72
1,594.80
1,221.36
934.45
710.27
544.70
458.33
Non Current Assets
7,311.54
8,129.77
8,595.61
8,713.53
8,704.89
4,512.74
4,085.66
3,768.25
1,599.69
1,191.87
Capital Work in Progress
629.82
889.38
711.93
617.12
646.94
519.49
1,041.58
678.33
534.11
285.28
Non Current Investment
42.33
42.09
2.09
2.09
0.09
0.09
0.09
0.06
0.03
0.03
Long Term Loans & Adv.
166.55
96.84
222.19
150.58
130.96
182.32
99.66
206.92
129.47
62.84
Other Non Current Assets
50.19
36.83
126.28
196.03
72.22
122.40
85.25
50.28
60.74
23.90
Current Assets
5,164.99
5,523.22
4,980.92
5,037.54
5,262.41
4,879.47
4,689.03
4,051.41
3,404.48
2,560.89
Current Investments
183.98
139.05
0.02
351.35
492.27
803.55
779.59
297.59
185.63
60.44
Inventories
2,462.32
2,681.20
2,148.22
1,935.15
1,966.30
1,559.15
1,357.98
1,067.17
1,006.06
923.86
Sundry Debtors
1,632.48
1,523.37
1,649.34
1,435.71
1,253.45
950.89
1,445.09
1,587.26
1,099.42
687.82
Cash & Bank
403.41
603.50
666.65
816.04
867.23
893.72
647.03
567.36
769.42
626.97
Other Current Assets
482.80
512.69
443.21
405.83
683.16
672.16
459.34
532.03
343.95
261.80
Short Term Loans & Adv.
67.13
63.41
73.48
93.46
95.39
82.62
90.18
109.09
84.95
75.95
Net Current Assets
749.90
631.60
-473.24
-127.78
60.24
2,141.21
1,403.55
1,227.66
1,229.90
850.24
Total Assets
12,476.53
13,652.99
13,576.53
13,751.07
13,967.30
9,392.21
8,774.69
7,819.66
5,004.17
3,752.76

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
1,802.99
2,005.35
1,392.91
1,798.08
894.15
1,008.84
2,742.12
810.20
599.42
153.48
PBT
1,225.91
1,526.26
1,186.57
561.66
931.01
1,088.09
2,343.44
939.81
843.98
581.60
Adjustment
1,349.95
992.84
876.21
1,418.19
606.92
430.27
552.44
337.96
136.79
126.13
Changes in Working Capital
-351.85
-338.25
-385.83
99.39
-360.16
-125.21
423.58
-409.38
-119.68
-421.75
Cash after chg. in Working capital
2,224.01
2,180.85
1,676.95
2,079.24
1,177.77
1,393.15
3,319.46
868.39
861.09
285.98
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-421.02
-175.50
-284.04
-281.16
-283.62
-384.31
-577.34
-58.19
-261.67
-132.50
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-196.63
-449.42
198.61
-241.28
-4,706.95
-786.91
-837.85
-2,162.30
-355.81
-241.70
Net Fixed Assets
-29.00
-198.83
-378.80
-610.74
-4,245.22
-592.01
-471.42
-2,266.57
-308.01
-455.28
Net Investments
-53.72
-179.03
351.33
138.83
310.79
-17.69
-484.32
-111.97
-131.60
287.55
Others
-113.91
-71.56
226.08
230.63
-772.52
-177.21
117.89
216.24
83.80
-73.97
Cash from Financing Activity
-1,781.05
-1,650.79
-1,549.04
-1,314.45
3,417.39
-192.91
-1,435.15
1,212.25
86.40
19.73
Net Cash Inflow / Outflow
-174.69
-94.86
42.48
242.35
-395.41
29.02
469.12
-139.85
330.01
-68.49
Opening Cash & Equivalents
572.56
661.82
588.76
702.04
1,067.57
1,049.86
612.38
955.05
687.41
760.80
Closing Cash & Equivalent
398.40
572.56
661.82
940.06
702.04
1,067.57
1,049.86
864.95
955.05
687.41

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
175.87
172.45
284.99
279.15
273.11
257.04
206.46
147.16
112.41
84.02
ROA
5.92%
9.20%
7.50%
3.15%
5.81%
10.28%
20.89%
11.71%
15.16%
12.79%
ROE
13.18%
23.49%
21.47%
9.34%
15.12%
23.80%
57.92%
34.19%
39.94%
33.25%
ROCE
14.35%
17.62%
15.28%
9.75%
13.81%
20.36%
45.63%
26.98%
35.06%
31.66%
Fixed Asset Turnover
1.43
1.43
1.48
1.50
1.57
1.35
1.82
1.88
3.11
2.60
Receivable days
37.86
38.92
37.65
33.78
35.74
74.66
82.76
105.19
77.81
68.65
Inventory Days
61.71
59.24
49.84
49.01
57.16
90.90
66.19
81.17
84.02
82.53
Payable days
306.08
383.19
133.47
139.05
150.99
171.27
204.35
176.11
158.58
143.69
Cash Conversion Cycle
-206.50
-285.04
-45.98
-56.26
-58.09
-5.72
-55.41
10.25
3.25
7.50
Total Debt/Equity
0.68
0.83
1.21
1.28
1.40
0.58
0.67
1.10
0.59
0.49
Interest Cover
5.81
5.32
3.63
2.11
4.02
6.29
13.74
6.37
15.40
18.21

News Update:


  • USFDA concludes pre-approval inspection at Torrent Pharmaceuticals’ Gujarat facility
    20th Mar 2023, 11:50 AM

    At the end of the inspection, the company has been issued a ‘Form 483’ with 1 observation, which is procedural in nature

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.